NCT02751502

Brief Summary

Twenty pediatric patients aged 5-17 years with Acquired Brain Injuries (ABI) will be randomized to receive either a bimanual-to-unimanual device home training program (10 subjects) or a conventional non-device home training program (10 subjects) for a period of 6 weeks. The specific aims of this proposal are to: Aim 1: Introduce home-based targeted upper limb training in children with hemiplegia from ABI (Acquired Brain Injuries) using a bimanual-to-unimanual training approach It is hypothesized that child-friendly home-based upper limb bimanual-to-unimanual training will lead to greater compliance and improved motor outcome on the Fugl Myer Scale compared to a conventional home training program. Aim 2: Improve the understanding of the pattern of recovery of isolated joint movements in the pediatric population with hemiplegia following ABI. It is hypothesized that individuals receiving device-based bimanual-to-unimanual training will show improvement in active range of motion across upper limb joints compared with a conventional home training program.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 19, 2016

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 26, 2016

Completed
8 months until next milestone

Study Start

First participant enrolled

January 1, 2017

Completed
4.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 9, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 9, 2021

Completed
1 year until next milestone

Results Posted

Study results publicly available

February 11, 2022

Completed
Last Updated

February 11, 2022

Status Verified

February 1, 2022

Enrollment Period

4.1 years

First QC Date

April 19, 2016

Results QC Date

January 20, 2022

Last Update Submit

February 10, 2022

Conditions

Keywords

ChildrenPediatricsArmUpper limbbimanual trainingphysical training

Outcome Measures

Primary Outcomes (2)

  • Change From Baseline in Quality of Bimanual Hand Measured by Fugl-Meyer Scale

    Measure of impairments in motor functioning and recovery in children post hemiplegia.

    6 Weeks

  • Change From Baseline in Timed Performance of Standardized Manual Activities Measured by Hand Assessment Test

    6 Weeks

Study Arms (2)

Bimanual-to-unimanual device home training program

EXPERIMENTAL
Device: m2 Bimanual Arm Trainer (BAT)

Conventional non-device home training program

NO INTERVENTION

Subjects receive 6 weeks of ongoing usual and customary care schedule of home physical and occupational therapy as usual and customary care independent of the study.

Interventions

Patients in the device group will be asked to train specific movements repeatedly with the device for 45 minutes five days a week for 6 weeks and compliance will be monitored through training logs and remotely

Bimanual-to-unimanual device home training program

Eligibility Criteria

Age5 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Acquired Brain Injury at least 3 months prior to enrollment.
  • Unilateral hemiparesis
  • History of compliance with home exercise programs in the past.

You may not qualify if:

  • Any social or medical problem that precludes compliance with the protocol
  • Comorbid seizure disorder or other neurological disease
  • Treatment with botulinum toxin or intrathecal baclofen in the 3 months preceding enrollment
  • Implanted neuromodulatory or electronic device or other complicating illness
  • Lack of capacity to consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

New York University Langone Medical Center

New York, New York, 10016, United States

Location

MeSH Terms

Conditions

Hemiplegia

Condition Hierarchy (Ancestors)

ParalysisNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Renat Sukhov, MD
Organization
NYU Langone Health

Study Officials

  • Renat Sukhov, MD

    NYU Langone Health

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 19, 2016

First Posted

April 26, 2016

Study Start

January 1, 2017

Primary Completion

February 9, 2021

Study Completion

February 9, 2021

Last Updated

February 11, 2022

Results First Posted

February 11, 2022

Record last verified: 2022-02

Locations